Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -9.45% is 275% below its 2-year average of 5.39%, near the low end of its 2-year range (-9.45%–24.56%).
As of the fiscal period ended Tuesday, March 31, 2026. 125.27% below its 12-month average of -4.19%.
Annual fiscal-year return on invested capital; no daily interpolation. Historical series through 2026-03-31.
RETURN ON INVESTED CAPITAL (ROIC)
-9.45%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-4.19%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-125.27%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+73.49%
vs the sector median at left
Cellyan Biotechnology Co., Ltd
Market Cap
$1.13M
Return on Invested Capital (ROIC)
-9.45%
TTM Avg
-4.19%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.12M
Return on Invested Capital (ROIC)
-183.49%
TTM Avg
-279.63%
3Y Avg
-279.63%
5Y Avg
-279.63%
Market Cap
$1.17M
Return on Invested Capital (ROIC)
-128.95%
TTM Avg
-69.60%
3Y Avg
-67.51%
5Y Avg
-50.89%
Market Cap
$1.08M
Return on Invested Capital (ROIC)
-60.41%
TTM Avg
-162.02%
3Y Avg
-321.37%
5Y Avg
-223.75%
Market Cap
$1.01M
Return on Invested Capital (ROIC)
-59.81%
TTM Avg
-3.58%
3Y Avg
-5.96%
5Y Avg
-5.96%
Market Cap
$946332.00
Return on Invested Capital (ROIC)
-18.56%
TTM Avg
-21.38%
3Y Avg
-25.71%
5Y Avg
-46.44%
Market Cap
$1.32M
Return on Invested Capital (ROIC)
-107.08%
TTM Avg
-750.62%
3Y Avg
-506.81%
5Y Avg
-355.90%
Market Cap
$1.33M
Return on Invested Capital (ROIC)
-32.53%
TTM Avg
-171.99%
3Y Avg
-201.88%
5Y Avg
-239.63%
Market Cap
$1.34M
Return on Invested Capital (ROIC)
-219.36%
TTM Avg
-214.97%
3Y Avg
-160.97%
5Y Avg
-133.06%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cellyan Biotechnology Co., Ltd (HKPD) | $1.13M | -9.45% | -4.19% | N/A | N/A |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.12M | -183.49% | -279.63% | -279.63% | -279.63% |
| IM Cannabis Corp. (IMCC)vs › | $1.17M | -128.95% | -69.60% | -67.51% | -50.89% |
| Clearmind Medicine Inc. (CMND)vs › | $1.08M | -60.41% | -162.02% | -321.37% | -223.75% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.01M | -59.81% | -3.58% | -5.96% | -5.96% |
| Sunshine Biopharma, Inc. (SBFM)vs › | $946332.00 | -18.56% | -21.38% | -25.71% | -46.44% |
| Genprex, Inc. (GNPX)vs › | $1.32M | -107.08% | -750.62% | -506.81% | -355.90% |
| NewcelX Ltd. (NCEL)vs › | $1.33M | -32.53% | -171.99% | -201.88% | -239.63% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.34M | -219.36% | -214.97% | -160.97% | -133.06% |
| GlucoTrack, Inc. (GCTK)vs › | $901902.00 | N/A | -416.12% | -338.16% | -243.59% |
ROIC
-9.4%
ROE
-11.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-03-31 | -9.45% |
| 2025-03-31 | 1.06% |
| 2024-03-31 | 24.56% |
